Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Mar 11:15:663245.
doi: 10.3389/fnins.2021.663245. eCollection 2021.

Editorial: Dopaminergic Alterations in Schizophrenia

Mark D Tricklebank  1 , Carol Tamminga  2 , Andrew Grottick  3 , Pierre M Llorca  4 , Silvia Gatti McArthur  5 , Jean-Claude Martel  6
Affiliations
Editorial

Editorial: Dopaminergic Alterations in Schizophrenia

Mark D Tricklebank et al. Front Neurosci. .
No abstract available

Keywords: PDE10 inhibition; antipsychotics; dopamine; neurocircuits; schizophrenia.

PubMed Disclaimer

Conflict of interest statement

SG is a co-owner of McArthur and Associates GmbH Basel Switzerland; and AG is an employee of Beacon Discovery, San Diego, CA, USA. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Dopaminergic Alterations in Schizophrenia

References

    1. Carlsson A., Lindqvist M. (1963). Effect of chlorpromazine or haloperidol on formation of 3methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol. Toxicol. 20, 140–144. - PubMed
    1. Correll C. U., Kane J. M. (2020). Ranking antipsychotics for efficacy and safety in schizophrenia. JAMA Psychiatr. 77, 225–226. - PubMed
    1. Creese I., Burt D. R., Snyder S. H. (1976a). Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192, 481–483. - PubMed
    1. Creese I., Burt D. R., Snyder S. H. (1976b). Dopamine receptors and average clinical doses. Science 194:546. - PubMed
    1. Madras B. K. (2013). History of the discovery of the antipsychotic dopamine D2 receptor: a basis for the dopamine hypothesis of schizophrenia. J. Hist. Neurosci. 22, 62–78. 10.1080/0964704X.2012.678199 - DOI - PubMed

Publication types

LinkOut - more resources